Premium
ISOTRETINOIN: COST‐BENEFIT STUDY
Author(s) -
Lee MayLian,
Cooper Alan
Publication year - 1991
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/j.1440-0960.1991.tb00675.x
Subject(s) - isotretinoin , medicine , acne , dermatology , medical prescription , antibiotics , pharmacology , microbiology and biotechnology , biology
S ummary Isotretinoin is a well‐established, effective treatment for severe nodutocystic acne. An important consideration which may limit the prescription of isotretinoin is its cost. Based on a literature review, we have compared isotretinoin with the conventional combination of antibiotics and topical therapies for the treatment of severe nodulocystic acne in terms of cost and benefit. Our results show that when duration of treatment is considered, isotretinoin is cheaper and significantly more effective.